DSS30

CAS No. 883027-32-5

DSS30( —— )

Catalog No. M35558 CAS No. 883027-32-5

DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 282 In Stock
5MG 472 In Stock
10MG 644 In Stock
25MG 905 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DSS30
  • Note
    Research use only, not for human use.
  • Brief Description
    DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).
  • Description
    DSS30 is a P25/CDK5 inhibitor that reduces β-amyloid (Aβ) secretion by inhibiting amyloid precursor protein lyase 1 (BACEl) phosphorylation. DSS30 can be used in the study of neurodegenerative diseases such as Alzheimer's disease.
  • In Vitro
    DSS30 (50 μM, 2 hours) inhibits the activity of the P25/CDK5 complex by up to 50% and the phosphorylation of BACE1 or Tau.Western Blot Analysis Cell Line:Expressed P25 PC12tet-off cell lines Concentration:50 μM Incubation Time:8 hours Result:Inhibited BACE1 phosphorylation by 12%.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    Beta Amyloid | CDK | BACE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    883027-32-5
  • Formula Weight
    367.87
  • Molecular Formula
    C16H14ClNO3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C(SC1S(NC3=C(OC)C=CC=C3)(=O)=O)=CC=C(Cl)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sul-Hee Chung, et al. Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease. WO2006075808
molnova catalog
related products
  • Otophylloside B

    Qingyangshengenin B is a C-21 steroidal glycoside isolated from Qingyangshen.?

  • PPI-1019

    PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).

  • MDR-1339

    MDR-1339 is a blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.